Skip to main content RSS Info Close Search Facebook Twitter
Location
Category
Providers / Vacancies
Feedback

Progress on Aust/NZ Therapeutic Products Authority

The Australian and New Zealand governments have moved closer towards establishing an Australia New Zealand Therapeutic Products Authority (ANZTPA). The aim of the proposed joint regulatory scheme for therapeutic products is to protect the health and safety of Australians and New Zealanders by regulating the safety, quality and effectiveness of prescription and over-the-counter medicines, complementary medicines, medical devices, tissue and cellular therapies, blood and blood products in both countries.

More than 1,000 industry, and other stakeholders and consumers have met in a round of public consultation meetings in New Zealand and Australia. This was followed up by a recent Ministerial meeting in New Zealand.

This meeting considered the plans for the second phase of consultation on the proposed joint regulatory scheme, expected to begin in mid-September 2006. This will include the release of the draft advertising rule, draft rule for blood and blood components, and the further aspects of the draft administration rule, such as scheduling.

The Ministers agreed in principle to the use of third parties for conformity assessment for Australian and New Zealand manufacturers of medical devices, with the ANZTPA making the licensing decision.

The ministerial meeting ratified the appointment of the chair, deputy chair and membership of a new Advertising Implementation Steering Group. The steering group will provide guidance on proposals for the joint regulation of the advertising of therapeutic products under the proposed Authority.

Former Liberal Senator Sue Knowles has been appointed as the chair of the steering group. She was a key member of Australia’s Senate Community Affairs Legislation Committee. Ms Knowles gained an extensive understanding of health, aged care, Indigenous health, welfare and related matters.

The Interim Ministerial Council also received an update on the regulatory framework for human cellular and tissue therapies, which would be regulated under the proposed ANZTPA. It was noted that consultation with stakeholder groups is currently under way to further develop the detail of the proposed regulatory scheme for human cellular and tissue therapies.

For information visit www.anztpa.org

Share this article

Read next

Subscribe

Subscribe to our Talking Aged Care newsletter to get our latest articles, delivered straight to your inbox
  1. Eighty years after getting married, this couple lives together...
  2. Who says your age should limit your dreams?
  3. Data from a recently released report highlights a concerning...
  4. With an ageing and growing population, data from the...
  5. Approximately 411,000 Australians are estimated to be living...
  6. How could you benefit from attending university as an older...

Recent articles

  1. What is a lesser known impact of hearing loss for older...
  2. Are there options for older Australians to live in the same...
  3. The new initiative brings older Aussies together to see the...
  4. A collaboration between Dementia Australia and VistaPrint...
  5. How can you look after yourself during the expected heatwaves...
  6. How is an interactive app being used in aged care settings to...
  7. How could the upcoming strengthening of super standards save...
  8. Brother Thomas Oliver Pickett, a Western Australian volunteer,...
  9. Why is an illegal website targeting older Australians?
  10. Eighty years after getting married, this couple lives together...
  11. How does heart health impact your risk of dementia?
  12. Instead of going to the hospital, could older Australians...
  1. {{ result.posted_at | timeago }}

Sorry, no results were found
Perhaps you misspelled your search query, or need to try using broader search terms.
Please type a topic to search
Some frequently searched topics are "dementia", "elderly" etc
Close